CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Australia
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
GlobalData, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Australia”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Australia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts. The population of Australia in 2015 was 23.86 million, having grown at a CAGR of 2% from 2008. Medicare is Australia’s public health insurance scheme, and provides free or subsidized healthcare services to the Australian population. The government is attempting to reduce the barriers to manufacturing drugs and encourage exports through the introduction of various new policies. In 2015, the government spent $22.03 billion on R&D on medical and health science and exported $3.53 billion of pharmaceutical products. The pharmaceutical market in Australia was worth $22.30 billion in 2015 and is projected to reach $25.20 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 2%. The medical device market was valued at $8.85 billion in 2015 and is projected to grow at a CAGR of 0.1% to $11.44 billion by 2020. These positive growth trends can be primarily attributed to: An increasingly elderly population Universal health coverage Government initiatives
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Australia, and includes:
An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: Alphapharm, Apotex, Aspen Pharmacare (Aspen), Pfizer and AstraZeneca; and profiles and SWOT analyses of the major players in the medical device market: GE Healthcare, Siemens Healthcare, Philips Healthcare, GSK and Alcon
An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
Detailed analysis of the country’s political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
An overview of the opportunities for and challenges to growth in the Australian healthcare market
Reasons to Buy
This report will enhance your decision-making capability by allowing you to:
Develop business strategies by understanding the trends shaping and driving Australia’s healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Australia’s healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Table of Contents
Table
Figures
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.